Apel Daniel Joseph has filed 4 insider transactions across 1 company since January 2026.
Most recent transaction: a sale of 3208 shares of ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) on April 22, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 22, 2026 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Apel Daniel Joseph | Chief Financial Officer | S | Common Stock | 3208 | $70.11 | 172,792.0000 | 140,706,000 | 1.82% | 0.00% |
| April 22, 2026 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Apel Daniel Joseph | Chief Financial Officer | S | Common Stock | 1157 | $70.45 | 171,635.0000 | 140,706,000 | 0.67% | 0.00% |
| April 22, 2026 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Apel Daniel Joseph | Chief Financial Officer | S | Common Stock | 8730 | $71.92 | 162,905.0000 | 140,706,000 | 5.09% | 0.01% |
| Jan. 6, 2026 | ARROWHEAD PHARMACEUTICALS, INC. | $ARWR | Apel Daniel Joseph | Chief Financial Officer | A | Common Stock | 75000 | $0.00 | 176,200.0000 | 140,706,000 | 74.11% | 0.05% |